BRD2 was remarkably elevated at the transcriptional level in parallel with BRD4, suggesting that BRD2 is probably associated with the pathological progression of cardiac hypertrophy (Li et al., 2021). The gene discussed is BRD2; the disease is cardiac hypertrophy.